活性依赖性神经保护因子(ADNP)多克隆抗体
Polyclonal Antibody to Activity Dependent Neuroprotector Protein (ADNP)
ADNP1; ADNP Homeobox 1; Activity-dependent neuroprotective protein
- 编号PAJ674Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPJ674Hu01-活性依赖性神经保护因子(ADNP)重组蛋白
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度0.5mg/ml
- 且适物种Sus scrofa; Porcine (Pig，猪)
- 应用WB
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
IHC图
-
Figure. Western Blot; Sample: Recombinant ADNP, Human.
-
Figure. Western Blot; Sample: Lane1: Human Lung Tissue; Lane2: Human Hela Cells; Lane3: Porcine Heart Tissue.
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对ADNP的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ADNP。
用法
Western blotting: 0.01-2µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPJ674Hu01 | 活性依赖性神经保护因子(ADNP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ674Hu01 | 活性依赖性神经保护因子(ADNP)多克隆抗体 | WB |
| MAJ674Hu21 | 活性依赖性神经保护因子(ADNP)单克隆抗体 | WB; IHC; ICC; IP. |
| SEJ674Hu | 活性依赖性神经保护因子(ADNP)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMJ674Hu | 活性依赖性神经保护因子(ADNP)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Journal of Proteomics | Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease [ScienceDirect: S1874391912002230] |
| J Alzheimers Dis | Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers [PubMed: 26639975] |
| Journal of Alzheimer's Disease | Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer’s Disease Biomarkers [pubmed:26639975] |
| Neuroscience Letters | Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia [Pubmed: 30172685] |
| Biomedicines | DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related … [Pubmed:35740400] |
留言咨询